Most patients titrate to maintenance within six months, so year 2 almost always costs more than year 1
He also discusses the limitations of current research, the importance of evidence-based addiction care, and what the future of GLP-1 therapies could mean for patients seeking recovery from alcohol and drug addiction
Data from the SUSTAIN and SCALE trials demonstrated that semaglutide therapy is associated with reductions in LDL cholesterol, total cholesterol, and triglycerides, alongside modest increases in HDL.[3,8] For patients already managing cardiovascular risk, this creates a meaningful opportunity: GLP-1-related lipid improvement may reduce or eliminate the need for statin therapy, but that conversation should be guided by lab data not assumptions
04 What you may notice: Peak results in skin quality, firmness, and elasticity
Following treatment, total and oxidized glutathione levels were measured according to the manufacturers instructions
